Diabetes Drug Market Outlook

1
Global Diabetes Drugs Market

2
Report Description and Highlights
Analyst View Global Diabetes Drugs Market is
projected to go beyond US 76 Billion by the end
of the year 2024. Diabetes is a health disorder
in which the level of blood glucose gets elevated
in the human body. In general Diabetes is a
chronic disease caused when pancreas cannot
effectively use the insulin it produces to
regulate the level of blood sugar in the human
body. Type 1 Diabetes Type 1 diabetes also
known by the name of juvenile or childhood-onset
or insulin-dependent diabetes is characterized by
the deficient insulin production and needs
insulin administration daily. The cause of type 1
diabetes is still unknown and is not curable with
existing knowledge. Type 2 Diabetes Type 2
diabetes formerly known as adult-onset or
non-insulin dependent diabetes results from the
human bodys ineffective use of insulin. Around
the world, the majority of the population
suffering from diabetes comprises of type 2
diabetes and is mainly caused due to body
overweight and physical inactivity. Until lately,
type 2 of diabetes was seen only among the adults
but now it is also occurring significantly among
the children.


3
Various Types of Diabetes Drugs in the Market
Diabetes is a serious disease and there is no
treatment available that can cure diabetes. All
over the world, diabetes prevalence is growing
rapidly specially in the middle and low-income
countries. Moreover, diabetes is also among the
primary reason of kidney failure, heart attacks,
strokes, lower limb amputation, and blindness.
Considering the seriousness of the disease, it
has dragged the interest of various
biopharmaceutical companies for developing
effective new lifesaving and life-changing drugs
for the treatment. Currently, a number of various
types of diabetes drugs are available in the
market and more than 170 diabetes drugs are in
their developmental stage which again provides a
seamless opportunity to the Diabetes Drugs
Market. Read more here https//www.renub.com/d
iabetes-drug-market-p.php

4
Forecast for Diabetes Drugs Market Share by
Insulin ()
Forecast for Diabetes Drugs Market Share by
Insulin (), 2018 - 2024

Source Renub Research Analysis Note These are
dummy figures actual data given in the report
5
420 Million adults suffering from diabetes in 2016
Some of the Diabetes Drugs Available in the
Market Include DPP-4 Inhibitors  These drugs
inhibit the enzyme DPP-4 which increases the
level of GLP-1 named hormone that stimulates the
insulin production in the human body and
decreases the production of glucagon hormone when
the level of blood glucose is high. Insulin
Drugs  Pancreas produced the hormone called
insulin which stimulates cells to remove glucose
from the blood in the human body. Usually,
insulin is released when the human body has a
high level of sugar in the blood to bring levels
back into a normal range. Over the last few
decades, the world has witnessed a considerable
increase in the diabetes population. According to
the International Diabetes Federation (IDF),
there were nearly 420 Million adults suffering
from diabetes in 2016 and is expected to
reach 625 Million by the year 2040. Want more
Information about this market? Request a free
sample copy https//www.renub.com/contactus.php


6
Global Forecast for Diabetes Drugs Market by
Therapy ()
Forecast for Diabetes Drugs Market by Therapy ()
2018 2024

Source Renub Research Analysis Note These are
dummy figures actual data given in the report
7
Key Topics Covered in Diabetes Drugs Market

• 1. Introduction
• 1.1 Market Definition
• 1.2 Currency Conversion
• 2. Research Methodology
• 3. Executive Summary
• 4. Global Diabetes Drug Market
• 5. Market Share Global Diabetes Drug
• 5.1 Disease Type 5.2 Therapy (Oral,
  Injection, Insulin)
• 5.3 Oral Drug 5.4 Injection Drug
• 5.5 Insulin 5.6 Regions Type 1
  Diabetes Drug
• 5.7 Regions Type 2 Diabetes Drug
• 6. Disease Type Global Diabetes Drug Market
• 6.1 Type 1 Diabetes 6.2 Type 2 Diabetes

8
Key Topics Covered in Diabetes Drugs Market

• Region Type 1 Diabetes Drug Market
• 8.1 United States 8.2 European Union
• 8.3 Japan 8.4 Canada
• Region Type 2 Diabetes Drug Market
• 9.1 United States 9.2 European Union
• 9.3 Japan 9.4 China
• 9.5 India 9.6 Brazil
• 10. Regions Diabetic Population
• 10.1 United States 10.2 European Union
• 10.3 Japan 10.4 Canada
• 10.5 China 10.6 India
• 10.7 Brazil
• 11. Key Players Analysis
• 11.1 Novo Nordisk Overview 11.2 Merck Co
  Overview
• 11.3 Eli Lilly Overview 11.4 AstraZeneca
  Overview
• 11.5 Johnson Johnson Overview 11.6
  Boehringer Ingelheim Overview

9
Global Diabetes Drugs Market

• Market Dynamics
• 13.1 Growth Drivers 13.2 Challenges
• 13.3 Opportunities
• Browse Related Report
• Epilepsy Drugs Market
• Allergic Conjunctivitis Market
• Contact Us
• Tel [phone] (US), 91-120-421-9822
  (INDIA)
• Email info_at_renub.com